The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2021
Filed:
Mar. 02, 2017
Applicant:
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, CN;
Inventors:
Xuemei Xu, Beijing, CN;
Xue Chen, Beijing, CN;
Ting Zhang, Beijing, CN;
Zhirong Wang, Beijing, CN;
Hongyang Liu, Beijing, CN;
Shuo Wang, Beijing, CN;
Meili Hu, Beijing, CN;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/01 (2006.01); C07K 14/025 (2006.01); A61K 39/12 (2006.01); C12N 15/62 (2006.01); C12N 15/70 (2006.01); C07K 14/005 (2006.01); C12N 15/63 (2006.01); C07K 19/00 (2006.01); A61P 31/20 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61P 31/20 (2018.01); C07K 19/00 (2013.01); C12N 15/63 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/575 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01);
Abstract
Provided is a papillomavirus chimeric protein, the skeleton thereof being a papillomavirus L1 protein or a mutant thereof, at least one human papillomavirus 33-type L2 protein or mutant polypeptide thereof being embedded on the skeleton. The present papillomavirus chimeric protein can be used for preparing a vaccine for preventing papillomavirus infections and infection induced disease.